Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Renata Medical, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Renata Medical, Inc.

Regulatory records
5
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 5 FDA records to the applicant name Renata Medical, Inc.. 3 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Sep 11, 2025 to Aug 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code PNF appears in 5 of the 5 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P240003, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 4695 Macarthur Ct., Suite 1150, Newport Beach, CA, 92660. Recorded on P240003/S008, decision dated Aug 27, 2026.

Changes described in PMA records

P240003/S008: Minima Stent System; Minima Pro Stent System

FDA’s recorded scope: Approval for the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240003.

Aug 27, 2026 · Normal 180 Day Track No User Fee

P240003/S006: Minima Pro Stent System

FDA’s recorded scope: Approval for design modifications and a line extension to the Minima Stent System, including a stent design change from closed cell to hybrid open-cell, a new 10mm balloon size for expansion of the stent, delivery system design changes, and packaging design changes. The device, as modified, will be marketed under the trade name Minima Pro Stent System.

Jul 9, 2026 · Normal 180 Day Track

P240003/S007: Minima Stent System

FDA’s recorded scope: a change to a process inspection acceptance criterion for the balloon shaft of the Minima Stent System

Feb 11, 2026 · 30-Day Notice

P240003/S005: Minima Stent System

FDA’s recorded scope: to move the dimensional inspection of the Minima Stent from a receiving step at the system assembly contract manufacturer, Medical Murray, to an outgoing inspection at the Minima Stent Manufacturer, Meko Laser

Dec 18, 2025 · 30-Day Notice

P240003/S004: Minima Stent System

FDA’s recorded scope: Approval for updates to the Instructions for Use labeling, including additional precautions, intended to enhance the safe use of the Minima Stent System.

Sep 11, 2025 · Special (Immediate Track)

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Renata Medical, Inc.PMA supplementAug 27, 2026FDA
Renata Medical, Inc.PMA supplementJul 9, 2026FDA
Renata Medical, Inc.PMA supplementFeb 11, 2026FDA
Renata Medical, Inc.PMA supplementDec 18, 2025FDA
Renata Medical, Inc.PMA supplementSep 11, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.